Coherus BioSciences (CHRS)
(Delayed Data from NSDQ)
$1.39 USD
-0.22 (-13.66%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $1.42 +0.03 (2.16%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.21 | 0.00% |
Earnings Summary
For their last quarter, Coherus BioSciences (CHRS) reported earnings of -$0.32 per share, missing the Zacks Consensus Estimate of -$0.05 per share. This reflects a negative earnings surprise of 540.00%. Look out for CHRS's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 44.74%.
Earnings History
Price & Consensus
Zacks News for CHRS
Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
CHRS: What are Zacks experts saying now?
Zacks Private Portfolio Services